WARPTECHNEWS · LAB

Home AI Business Tech Archive

Storia: US regulators approve Moderna flu vaccine — Warptech Lab News

Storia in 20 fonti

US regulators approve Moderna flu vaccine

The company's first mRNA-based flu vaccine, mFLUSIVA, has been approved for use in all adults age 50 and older

Raccontata da

biopharmadive.com

morningstar.com

fiercepharma.com

euronews.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

iol.co.zaStai leggendo1 g fa

US regulators approve Moderna flu vaccine

The company's first mRNA-based flu vaccine, mFLUSIVA, has been approved for use in all adults age 50 and older

Timeline cronologica

giovedì 6 agosto 2026·npr.org
A new flu vaccine geared to older people is coming soon
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
giovedì 6 agosto 2026·healio.com
FDA approves first mRNA flu shot, mFlusiva
The FDA has approved the nation’s first messenger RNA-based influenza vaccine, marking a significant development in the fight against the respiratory illness — and the end of a…

1 g fa

U.S. FDA approves first mRNA flu shot from Moderna

Moderna's mFlusiva becomes the first mRNA flu vaccine approved by the FDA for adults 50 and older.

Leggi questa versione → originale

cbsnews.com1 g fa

FDA approves Moderna's mRNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

Leggi questa versione → originale

biopharmadive.com1 g fa

FDA approves Moderna’s mRNA flu vaccine

The clearance paves the way for the first preventive flu shot based on mRNA technology and completes a dramatic regulatory turnaround.

Leggi questa versione → originale

arstechnica.com19 h fa

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

Leggi questa versione → originale

qz.com18 h fa

FDA approves Moderna's first mRNA flu vaccine mFlusiva

The vaccine, called mFlusiva, is the first mRNA-based flu shot to receive regulatory approval anywhere in the world

Leggi questa versione → originale

giovedì 6 agosto 2026·

biopharmadive.com

FDA approves Moderna’s mRNA flu vaccine

The clearance paves the way for the first preventive flu shot based on mRNA technology and completes a dramatic regulatory turnaround.

giovedì 6 agosto 2026·

forbes.com

FDA Approves First mRNA Flu Vaccine For Older Adults

The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.

giovedì 6 agosto 2026·

statnews.com

FDA approves Moderna’s mRNA flu vaccine, the first to use the technology

The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.

giovedì 6 agosto 2026·

nbcnews.com

FDA approves 1st mRNA flu shot, from Moderna

The vaccine, called mFlusiva, was approved for older adults. In trials, it was found to be about 27% more effective than a standard flu shot.

giovedì 6 agosto 2026·

cnn.com

FDA approves first mRNA-based flu vaccine | CNN

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.

giovedì 6 agosto 2026·

morningstar.com

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be available in select retailers in the coming weeks CAMBRIDGE,…

giovedì 6 agosto 2026·

cbsnews.com

FDA approves Moderna's mRNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

giovedì 6 agosto 2026·

abcnews.com

FDA approves Moderna's mRNA seasonal flu vaccine

The Food and Drug Administration approved Moderna's mRNA seasonal flu vaccine on Wednesday.

giovedì 6 agosto 2026·

fiercepharma.com

Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio

Despite a major curveball thrown by the FDA earlier this year, Moderna has managed to strike true with a U.S. approval for its mRNA-based influenza vaccine. | Despite a major…

giovedì 6 agosto 2026·

euronews.com

Medicines watchdog approves first-ever mRNA-based flu shot in the US

The US medicines regulator approved the first-ever mRNA-based vaccine in the US against flu for seniors.

giovedì 6 agosto 2026·

iol.co.za

US regulators approve Moderna flu vaccine

The company's first mRNA-based flu vaccine, mFLUSIVA, has been approved for use in all adults age 50 and older

giovedì 6 agosto 2026·

www1.folha.uol.com.br

Agência americana autoriza vacina contra a gripe da Moderna

Agência havia rejeitado análise inicial por considerar testes insuficientes

giovedì 6 agosto 2026·

thehindu.com

U.S. FDA approves first mRNA flu shot from Moderna

Moderna's mFlusiva becomes the first mRNA flu vaccine approved by the FDA for adults 50 and older.

giovedì 6 agosto 2026·

apnews.com

New kind of flu shot is on the way as the FDA approves Moderna's mRNA-based vaccine

The Food and Drug Administration has approved a new flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.

giovedì 6 agosto 2026·

thestar.com

New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key

giovedì 6 agosto 2026·

washingtonexaminer.com

FDA approves first ever mRNA flu vaccine

The vaccine, developed by Moderna, is approved for adults ages 50 to 64 and those 65 and older, who face the highest risk of severe illness.

giovedì 6 agosto 2026·

scientificamerican.com

U.S. approves Moderna's mRNA vaccine for flu—the first of its kind

The shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab

giovedì 6 agosto 2026·

upi.com

FDA approves new mRNA-based flu vaccine - UPI.com

The U.S. Food and Drug Administration has approved a new mRNA-based seasonal flu vaccine for people 50 and older, Moderna said this week.

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com